Philip Probert
Director of Biologics and Rna Centre of Excellence @Cpi
Signup · Get unlimited contacts
WORK HISTORY
Director of Biologics and Rna Centre of Excellence @Cpi
Darlington, GB
As Director of the Biologics & RNA Centre of Excellence, I provide strategic and operational leadership for CPI’s National Biologics Manufacturing Centre. I am responsible for ensuring safe, compliant, and effective GMP manufacture of advanced biopharmaceuticals, while driving innovation, capability development, and external partnerships that support the UK’s biopharma sector.In this role, I:Lead and develop a multidisciplinary team, building sustainable capability across biologics and RNA technologies to accelerate customer and collaborator programmes.Maintain compliance with GMP, data integrity, and quality systems to ensure that products are consistently safe, effective, and fit for purpose.Oversee delivery of CPI’s business plans by balancing revenue, cost profile, and engagement targets across academic, SME, and large biopharma partners.Champion continuous improvement in SHE, quality, and operational standards, fostering a culture of accountability and professional growth.Build collaborative networks across industry, academia, and government, positioning CPI as a leader in bioprocess innovation and advanced manufacturing.
EDUCATION
Newcastle University
Doctor of Philosophy (Ph.D.), Toxicology
Durham University
Bachelor’s Degree, Cell Biology
The Open University
Master of Business Administration - MBA
Newcastle University
Masters of Research, Toxicology
SKILLS
ABOUT PHILIP PROBERT
I am a technology leader and experienced operations manager, with over 15 years’ experience spanning academic research, industry applications, and biopharmaceutical innovation. Currently serving as Director of the Biologics and RNA Centre of Excellence at CPI, I lead a team of >70 bioprocessing professionals delivering cutting-edge programmes across biologics and mRNA.My career has focused on building and scaling capabilities that bridge science, strategy, and delivery. At CPI I’ve overseen growth in revenues, capability expansion into RNA-LNP, and the development of systems that enable high-performing teams across upstream, downstream, analytical and formulation groups. Our projects span recombinant proteins, monoclonal antibodies, viral vectors, plasmid DNA, and mRNA — all with the goal of accelerating customer programmes and enabling impact for patients.I am passionate about:Building sustainable and commercially viable bioprocesses that meet the needs of a rapidly evolving global market.Team development and leadership, creating environments where scientists can grow, innovate, and deliver.Collaborative partnerships, working with customers, regulators, and academics to drive next-generation therapies forward.I thrive at the intersection of science, strategy, and leadership — shaping systems that not only deliver today but build the foundations for tomorrow’s breakthroughs.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.